Gregory Duncan
Directeur Général chez VIRIOS THERAPEUTICS, INC.
Fortune : 26 202 $ au 30/04/2024
Postes actifs de Gregory Duncan
Sociétés | Poste | Début | Fin |
---|---|---|---|
VIRIOS THERAPEUTICS, INC. | Directeur Général | 01/04/2020 | - |
Président | 01/01/2018 | - | |
CORMEDIX INC. | Directeur/Membre du Conseil | 02/11/2020 | - |
Independent Dir/Board Member | 02/11/2020 | - | |
Center for Global Health Innovation, Inc.
Center for Global Health Innovation, Inc. BiotechnologyHealth Technology Center for Global Health Innovation, Inc. is a member of Georgia Bio, a non-profit life sciences association in Georgia. The non-profit company is based in Atlanta, GA. Georgia Bio works with various organizations to shape public policy, improve access to innovative technologies, and grow Georgia's life sciences economy. The CEO of the company is Maria Thacker-Goethe. | Directeur/Membre du Conseil | - | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Membre du Conseil | 17/08/2011 | - |
American Psychiatric Foundation | Directeur/Membre du Conseil | - | - |
Southeast BIO | Directeur/Membre du Conseil | - | - |
Biotie Therapeutics Corp. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Gregory Duncan
Anciens postes connus de Gregory Duncan
Sociétés | Poste | Début | Fin |
---|---|---|---|
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Directeur/Membre du Conseil | 08/01/2014 | 01/03/2020 |
Directeur Général | 08/01/2014 | 01/03/2020 | |
President | 08/01/2014 | 01/03/2020 | |
UCB | Corporate Officer/Principal | 17/08/2011 | 01/02/2013 |
░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Gregory Duncan
Emory University | Masters Business Admin |
State University of New York at Albany | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 11 |
Belgique | 2 |
Finlande | 2 |
Opérationnelle
Director/Board Member | 7 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
UCB | Health Technology |
VIRIOS THERAPEUTICS, INC. | Health Technology |
CORMEDIX INC. | Health Technology |
PFIZER, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Center for Global Health Innovation, Inc.
Center for Global Health Innovation, Inc. BiotechnologyHealth Technology Center for Global Health Innovation, Inc. is a member of Georgia Bio, a non-profit life sciences association in Georgia. The non-profit company is based in Atlanta, GA. Georgia Bio works with various organizations to shape public policy, improve access to innovative technologies, and grow Georgia's life sciences economy. The CEO of the company is Maria Thacker-Goethe. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
American Psychiatric Foundation | |
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
Southeast BIO | |
Biotie Therapeutics Corp. |
- Bourse
- Insiders
- Gregory Duncan
- Expérience